Consolidated Statements of Earnings - USD ($) shares in Millions, $ in Millions	3 Months Ended
Sep. 30, 2016	Sep. 30, 2015
Revenue	$ 32,039	$ 28,055
Cost of products sold	30,449	26,476
Gross margin	1,590	1,579
Operating expenses:
Distribution, selling, general, and administrative expenses	920	842
Restructuring and employee severance	9	12
Amortization and other acquisition-related costs	122	105
Impairments and (gain)/loss on disposal of assets, net	3	0
Litigation (recoveries)/charges, net	1	0
Operating earnings	535	620
Other (income)/expense, net	(3)	8
Interest expense, net	44	44
Earnings before income taxes	494	568
Provision for income taxes	184	184
Net earnings	310	384
Net earnings attributable to noncontrolling interests	1	1
Net earnings attributable to Cardinal Health, Inc.	$ 309	$ 383
Earnings per common share attributable to Cardinal Health, Inc.:
Basic (in shares)	$ 0.97	$ 1.17
Diluted (in shares)	$ 0.96	$ 1.15
Weighted-average number of common shares outstanding:
Basic (in shares)	320	328
Diluted (in shares)	322	331
Cash dividends declared per common share	$ 0.4489	$ 0.3870

The aggregate expense charged against earnings to allocate the cost of acquired intangible assets and changes in the fair value of contingent consideration obligations. This also represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.

No definition available.